Arlington, MA, United States of America

Eunice Sun Park

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 14.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eunice Sun Park

Introduction

Eunice Sun Park, an esteemed inventor based in Arlington, MA, has made noteworthy contributions to the field of cancer research and treatment through her innovative applications and patents. With a total of four patents to her name, her work primarily focuses on splice variants associated with neomorphic SF3B1 mutations, which hold significant implications for cancer diagnosis and treatment.

Latest Patents

Among her recent patents are several related to splice variants associated with neomorphic SF3B1 mutants. These patents describe methods for detecting these splice variants and their uses in diagnosing cancer, evaluating modulators of SF3B1, and developing methods for treating cancers linked with mutations in SF3B1. This groundbreaking research not only enhances our understanding of cancer biology but also paves the way for innovative therapeutic strategies.

Career Highlights

Eunice is currently working at Eisai R&D Management Co., Ltd., where she continues to push the boundaries of scientific innovation. Her dedication to research and development has established her as a prominent figure in her field, contributing significantly to advancements in cancer therapeutics.

Collaborations

During her career, Eunice has collaborated with notable colleagues such as Silvia Buonamici and Lihua Yu. These partnerships have fostered an environment of innovation and have facilitated the exchange of ideas, leading to impactful research outcomes.

Conclusion

Eunice Sun Park stands as a testament to the power of innovation in the medical field. Her groundbreaking patents and collaborations underscore her commitment to advancing cancer research and improving patient outcomes. As her work continues to evolve, it undoubtedly holds the potential to change the landscape of cancer treatment significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…